Sugi Predict

Sugi Predict / Compounds / SCHEMBL843524

SCHEMBL843524

SCHEMBL843524

COC(=O)c1cncn1C1c2ccccc2N(C)C(=O)C1(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 2/20 0.47
▸ MAPK1 P28482 1/20 0.39
▸ HDAC4 P56524 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC5 Q9UQL6 1/20 0.37
▸ HSD11B1 P28845 8/20 0.36
▸ GAA P10253 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ LMNA P02545 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2818227 0.82 CYP11B2 (0.58) CYP11B2MAPK1GAATSHRL3MBTL1
SCHEMBL843123 0.80 CYP11B2 (0.45) CYP11B2MAPK1HDAC4HDAC7HDAC5
SCHEMBL842386 0.79 CYP11B2 (0.48) CYP11B2MAPK1LMNAMAPTIDO1
SCHEMBL9777264 0.78 CYP11B2 (0.56) CYP11B2MAPK1TSHRIDO1CYP11B1
SCHEMBL2817705 0.76 CYP11B2 (0.45) CYP11B2MAPK1GAATSHRMEN1
SCHEMBL1097321 0.76 CYP11B2 (0.54) CYP11B2MAPK1GAATSHRMEN1
SCHEMBL9777356 0.76 CYP11B2 (0.48) CYP11B2MAPK1GAATSHRLMNA
SCHEMBL9494229 0.75 CYP11B2 (0.47) CYP11B2MAPK1GAATSHRL3MBTL1
SCHEMBL842330 0.75 CYP11B2 (0.42) CYP11B2MAPK1GAATSHRMEN1
SCHEMBL1098831 0.75 CYP11B2 (0.79) CYP11B2MAPK1GAATSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143278-B2 Organic compounds NOVARTIS AG (CH) 2012-03-27 — — US disclosed
US-8143278-B2 Organic compounds NOVARTIS AG (CH) 2012-03-27 — — US disclosed
US-8143278-B2 Organic compounds NOVARTIS AG (CH) 2012-03-27 — — US disclosed
US-20100093711-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-04-15 — — US disclosed
US-20100093711-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-04-15 — — US disclosed
US-20100093711-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-04-15 — — US disclosed
EP-2121652-A1 4-IMIDAZOLYL-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS ALDOSTERONE/11-BETA-HYDROXYLASE INHIBITORS Novartis AG (CH) 2009-11-25 — — EP disclosed
WO-2008076860-A1 4-IMIDAZOLYL-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS ALDOSTERONE/11-BETA-HYDROXYLASE INHIBITORS NOVARTIS AG (CH) 2008-06-26 — — WO disclosed
WO-2008076860-A1 4-IMIDAZOLYL-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS ALDOSTERONE/11-BETA-HYDROXYLASE INHIBITORS NOVARTIS AG (CH) 2008-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093711-A1 ORGANIC COMPOUNDS CYP11B1, HSD11B1, CYP11B2 CYP11B2 3/4885MAPK1 1399/4885HDAC4 1766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.